Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
biotech
cancer
4
×
immunotherapy
4
×
life sciences
national blog main
pfizer
san diego blog main
san diego top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cell therapy
clinical trials
global blood therapeutics
merck
novartis
spark therapeutics
#ash2018
What
annual
ash
bio
cancer
conference
medical
society
advantages
american
approved
bar
barcelona
blood
borne
brings
cancers
clinical
combo
companies
dating
december's
diego
drug
esmo
european
expect
gamble
game
gathering
guide
happening
hematology
host
immunotherapies
kgaa
kras
largest
latest
major
market
Language
unset
Current search:
amgen
×
cancer
×
immunotherapy
×
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More